Condition: Diabetes Mellitus, Type 1 · Sponsor: University of Chicago
The purpose of this study is to learn about the safety of islet transplantation for Type 1 diabetes mellitus, which may provide more normal control of blood sugar without the need for insulin shots. Islets are special clusters of cells within the pancreas that produce insulin. These cells will be obtained from cadaver (non-living) donors and given to subjects by vein.
This description comes directly from the study's public registry record.
Lindsay Basto, RN, BSN · 773-702-2504 · Lindsay.Basto@uchospitals.edu
Piotr Witkowski, MD, PhD · (773) 702-2447 · pwitkowski@surgery.bsd.uchicago.edu
Always discuss trial participation with your own doctor first.
| University of Chicago Medical Center | Chicago, Illinois, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT01630850